人体研究 MANP：新型人 ANP（心钠肽）类似物在人类高血压中的应用。
First-in-Human Study of MANP: A Novel ANP (Atrial Natriuretic Peptide) Analog in Human Hypertension.
机构信息
Cardiorenal Research Laboratory, Department of Cardiovascular Medicine, Mayo Clinic, Rochester MN (H.H.C., S.R.I., J.S., J.C.B.).
Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (S.-H.W.).
出版信息
Hypertension. 2021 Dec;78(6):1859-1867. doi: 10.1161/HYPERTENSIONAHA.121.17159. Epub 2021 Oct 18.
Abstract
[Figure: see text].
摘要
[图：见正文]。
相似文献
1
First-in-Human Study of MANP: A Novel ANP (Atrial Natriuretic Peptide) Analog in Human Hypertension.人体研究 MANP：新型人 ANP（心钠肽）类似物在人类高血压中的应用。
Hypertension. 2021 Dec;78(6):1859-1867. doi: 10.1161/HYPERTENSIONAHA.121.17159. Epub 2021 Oct 18.
2
Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.在原发性高血压中，对低剂量心房利钠肽输注的压力依赖性利钠反应增强。
J Intern Med. 1994 Dec;236(6):665-74. doi: 10.1111/j.1365-2796.1994.tb00860.x.
3
4
A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension.一种新型基于心钠肽的治疗药物在实验性血管紧张素 II 介导的急性高血压中的应用。
Hypertension. 2010 Dec;56(6):1152-9. doi: 10.1161/HYPERTENSIONAHA.110.159210. Epub 2010 Oct 25.
5
MANP (M-Atrial Natriuretic Peptide) Reduces Blood Pressure and Furosemide-Induced Increase in Aldosterone in Hypertension.M 型心钠肽（MANP）可降低血压并减少速尿引起的高血压患者醛固酮的增加。
Hypertension. 2022 Apr;79(4):750-760. doi: 10.1161/HYPERTENSIONAHA.121.18837. Epub 2022 Jan 20.
6
Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.等摩尔心房利钠肽和脑利钠肽输注对正常男性的不同生物学效应。
J Clin Endocrinol Metab. 1996 Nov;81(11):3871-6. doi: 10.1210/jcem.81.11.8923831.
7
M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics.在犬实验性急性高血压性心力衰竭模型中，M 型心房利钠肽和硝酸甘油：两种 cGMP 激活治疗药物的不同作用。
J Am Heart Assoc. 2014 Jan 2;3(1):e000206. doi: 10.1161/JAHA.113.000206.
8
Effect of chronic infusion of atrial natriuretic factor on plasma and urinary aldosterone, plasma renin activity, blood pressure and sodium excretion in 2-K, 1-C hypertensive rats.慢性输注心房利钠因子对二肾一夹高血压大鼠血浆及尿醛固酮、血浆肾素活性、血压和钠排泄的影响
Clin Exp Hypertens A. 1986;8(7):1127-47. doi: 10.3109/10641968609045478.
9
Effects of chronically administered atrial natriuretic factor in aldosterone-infused hypertensive rats.长期给予心房利钠因子对醛固酮灌注高血压大鼠的影响。
Jpn Circ J. 1988 Dec;52(12):1446-9. doi: 10.1253/jcj.52.1446.
10
Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes.利拉鲁肽可促进排钠，但不会增加 2 型糖尿病高血压患者的循环心房钠尿肽水平。
Diabetes Care. 2015 Jan;38(1):132-9. doi: 10.2337/dc14-1958. Epub 2014 Nov 20.
引用本文的文献
1
Inhibiting atrial natriuretic peptide clearance reduces myocardial fibrosis and improves cardiac function in diabetic rats.抑制心房利钠肽清除可减轻糖尿病大鼠的心肌纤维化并改善心脏功能。
Eur Heart J Open. 2025 Mar 19;5(2):oeaf031. doi: 10.1093/ehjopen/oeaf031. eCollection 2025 Mar.
2
The Balance Between the Natriuretic Peptides and the Renin-Angiotensin-Aldosterone System in the Preservation of Ideal Cardiovascular Health.利钠肽与肾素-血管紧张素-醛固酮系统在维持理想心血管健康中的平衡
J Clin Med. 2025 Jan 19;14(2):626. doi: 10.3390/jcm14020626.
3
Cross talk on therapeutic strategies: natriuretic peptides and inhibiting neprilysin in hypertension management.治疗策略中的相互作用：利钠肽与抑制中性肽链内切酶在高血压管理中的应用
Hypertens Res. 2025 Jan;48(1):284-300. doi: 10.1038/s41440-024-01989-w. Epub 2024 Nov 14.
4
Discovery of small molecule guanylyl cyclase B receptor positive allosteric modulators.小分子鸟苷酸环化酶B受体正变构调节剂的发现。
PNAS Nexus. 2024 Jun 6;3(6):pgae225. doi: 10.1093/pnasnexus/pgae225. eCollection 2024 Jun.
5
Porous silicon and silica carriers for delivery of peptide therapeutics.多孔硅和硅载体用于肽类治疗药物的递送。
Drug Deliv Transl Res. 2024 Dec;14(12):3549-3567. doi: 10.1007/s13346-024-01609-7. Epub 2024 May 31.
6
MANP in Hypertension With Metabolic Syndrome: Proof-of-Concept Study of Natriuretic Peptide-Based Therapy for Cardiometabolic Disease.利钠肽治疗心脏代谢疾病在高血压合并代谢综合征中的应用：概念验证研究
JACC Basic Transl Sci. 2023 Nov 1;9(1):18-29. doi: 10.1016/j.jacbts.2023.08.011. eCollection 2024 Jan.
7
Sex-based differences in metabolic protection by the ANP genetic variant rs5068 in the general population.在普通人群中，ANP 基因变异 rs5068 对代谢的保护作用存在性别差异。
Am J Physiol Heart Circ Physiol. 2023 Sep 1;325(3):H545-H552. doi: 10.1152/ajpheart.00321.2023. Epub 2023 Jul 7.
8
zDHHC9 Regulates Cardiomyocyte Rab3a Activity and Atrial Natriuretic Peptide Secretion Through Palmitoylation of Rab3gap1.zDHHC9通过Rab3gap1的棕榈酰化调节心肌细胞Rab3a活性和心钠素分泌。
JACC Basic Transl Sci. 2023 Feb 22;8(5):518-542. doi: 10.1016/j.jacbts.2022.11.003. eCollection 2023 May.
9
The Natriuretic Peptide System: A Single Entity, Pleiotropic Effects.利钠肽系统：单一实体，多种效应。
Int J Mol Sci. 2023 Jun 1;24(11):9642. doi: 10.3390/ijms24119642.
10
Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms.利钠肽：基于其分子机制的靶向治疗策略的时代已经到来。
Int J Mol Sci. 2023 Mar 7;24(6):5131. doi: 10.3390/ijms24065131.
本文引用的文献
1
Angiotensin (1-12) in Humans With Normal Blood Pressure and Primary Hypertension.正常血压和原发性高血压患者体内的血管紧张素（1-12）
Hypertension. 2021 Mar 3;77(3):882-890. doi: 10.1161/HYPERTENSIONAHA.120.16514. Epub 2021 Jan 19.
2
Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018.美国成年人高血压患者血压控制趋势，1999-2000 年至 2017-2018 年。
JAMA. 2020 Sep 22;324(12):1190-1200. doi: 10.1001/jama.2020.14545.
3
Cardiac natriuretic peptides.心脏利钠肽。
Nat Rev Cardiol. 2020 Nov;17(11):698-717. doi: 10.1038/s41569-020-0381-0. Epub 2020 May 22.
4
Report of the National Heart, Lung, and Blood Institute Working Group on Hypertension: Barriers to Translation.美国国立心肺血液研究所高血压工作组报告：转化障碍。
Hypertension. 2020 Apr;75(4):902-917. doi: 10.1161/HYPERTENSIONAHA.119.13887. Epub 2020 Feb 17.
5
Long-term blood pressure lowering and cGMP-activating actions of the novel ANP analog MANP.新型 ANP 类似物 MANP 的长期降压和 cGMP 激活作用。
Am J Physiol Regul Integr Comp Physiol. 2020 Apr 1;318(4):R669-R676. doi: 10.1152/ajpregu.00354.2019. Epub 2020 Feb 5.
6
Blood Pressure-Associated Genetic Variants in the Natriuretic Peptide Receptor 1 Gene Modulate Guanylate Cyclase Activity.利钠肽受体 1 基因中的血压相关遗传变异调节鸟苷酸环化酶活性。
Circ Genom Precis Med. 2019 Aug;12(8):e002472. doi: 10.1161/CIRCGEN.119.002472. Epub 2019 Aug 20.
7
Discovery of -glycans on atrial natriuretic peptide (ANP) that affect both its proteolytic degradation and potency at its cognate receptor.发现心钠肽（ANP）上的 - 聚糖会影响其在同源受体上的蛋白水解降解和效力。
J Biol Chem. 2019 Aug 23;294(34):12567-12578. doi: 10.1074/jbc.RA119.008102. Epub 2019 Jun 11.
8
Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver Angiotensinogen.小干扰 RNA 靶向肝脏血管紧张素原的强效和持久降压作用。
Hypertension. 2019 Jun;73(6):1249-1257. doi: 10.1161/HYPERTENSIONAHA.119.12703.
9
Molecular Implications of Natriuretic Peptides in the Protection from Hypertension and Target Organ Damage Development.利钠肽在预防高血压和靶器官损伤发展中的分子意义。
Int J Mol Sci. 2019 Feb 13;20(4):798. doi: 10.3390/ijms20040798.
10
CRRL269: a novel designer and renal-enhancing pGC-A peptide activator.CRRL269：一种新型的设计型且具有肾脏增强作用的pGC-A肽激活剂。
Am J Physiol Regul Integr Comp Physiol. 2018 Mar 1;314(3):R407-R414. doi: 10.1152/ajpregu.00286.2017. Epub 2017 Nov 29.
Zotero 插件